FDA-approved drug shows promise against ALS in mice

Accumulating evidence suggests that inflammatory processes may play a role in the initiation and progression of amyotrophic lateral sclerosis (ALS).

Harvard Gazette • harvard
Nov. 27, 2019 • ~3 min

/

1